Deciding whether or not to go non-GMO? Here are five points to consider.
When it comes to genetically modified organisms (GMOs), popularity is a relative term.
According to a USDA report released last year, American farmers planted about 169 million acres of genetically engineered corn, soybeans, and cotton in 2013 alone, citing increased yields as their primary motivation. These acres represent half of the total land used in America to grow crops. The result? According to the third-party certification program the Non-GMO Project (Bellingham, WA), about 80% of the conventional processed foods currently on American supermarket shelves are genetically engineered.
However, the popularity enjoyed by GMOs among farmers doesn’t quite seem to translate among consumers. Three-quarters of respondents in a 2013 poll by The New York Times expressed concern about genetically modified ingredients, mostly because of potential health risks. And a whopping 93% of respondents wanted GMO products to be labeled.
According to the Non-GMO Project, consumers are also wary of the herbicide tolerance of GMOs (which yield superbugs, superweeds...and super pesticides), as well as the social and economic implications of companies’ ability to sue farmers who grow their patented seeds-either willingly or unwillingly via inevitable drift from neighboring fields.
These shopper concerns are manifesting themselves in sales trends. Packaged Facts reports that sales of U.S. non-GMO food and drinks reached $200 million last year. And if GMO labeling were ever to become mandatory in the United States, non-GMO sales could skyrocket higher.But many companies aren’t willing to wait for federal or state regulators to develop GMO-labeling laws; instead, they’re taking matters into their own hands and voluntarily acquiring non-GMO certifications to meet consumer demand. Here are the business costs and benefits manufacturers and suppliers need to know before taking the plunge.
Photo © iStockphoto.com/zmeel
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.